---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-205044"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:35:10.644359+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics grants stock options to four top executives at $1.38 per share

## Summary
- CEO Pete O'Heeron granted options for 92,410 shares; CFO, CSO, and General Counsel each granted 61,607 shares.
- Vesting: 1/4th on first anniversary, then monthly over 36 months, subject to continuous service.
- Total of 277,231 stock options granted under the 2022 Stock Plan on May 4, 2026.

## SEC filing metadata
- accession: 0001193125-26-205044
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000119312526205044/0001193125-26-205044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526205044/fblg-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-205044
- JSON: https://secwatch.observer/filing/0001193125-26-205044.json
- Plain text: https://secwatch.observer/filing/0001193125-26-205044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.